Improving Low ASPECTS Stroke Thrombectomy
Key facts
- Where
- Berlin, Bremen, Hamburg, Kaiserslautern, Marburg, Münster és Rostock, NémetországSee the 7 sites
Where in Németország
- Charite University, BerlinBerlin, NémetországCsak meghívásos
- Hospital Bremen-MitteBremen, NémetországCsak meghívásos
- University Medical Center Hamburg-EppendorfHamburg, NémetországTaking people
- WestpfalzklinikumKaiserslautern, NémetországCsak meghívásos
- University Hospital MarburgMarburg, NémetországTaking people
- University MünsterMünster, NémetországCsak meghívásos
- University RostockRostock, NémetországCsak meghívásos
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitätsklinikum Hamburg-Eppendorf
- Trial code
- NCT04862507
- Record updated
- 2023. május 24.
- Original description
Improving Low ASPECTS Stroke Thromectomy (I-LAST) is an academic, independent, prospective, multicenter, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome. Advanced imaging biomarkers will be tested and validated aiming to improve treatment selection and outcome prediction of patients presenting with extensive baseline infarction.Read full original descriptionShow less
Improving Low Alberta Stroke Program Early ct Score Stroke Thrombectomy
Improving Low ASPECTS Stroke Thromectomy (I-LAST) is an academic, independent, prospective, multicenter, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome. Advanced imaging biomarkers will be tested and validated aiming to improve treatment selection and outcome prediction of patients presenting with extensive baseline infarction.
Inclusion: Clinical diagnosis of acute ischemic stroke; ASPECTS of 0-5; Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms; Age >18 years; Ethic approval in process.
Exclusion: none.